🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to estimate the annualized relapse ra...
Status
Completed
Location
Research Site
Start Date
2013-10-31
Trial ID
NCT01930708
Treatments Being Tested
The main objectives of Part 1 are as follows: To evaluate the safety, toler...
Status
Completed
Location
Boston Children's Hospital
Start Date
2014-08-28
Trial ID
NCT02283853
Treatments Being Tested
The primary objective of the study is to estimate the annualized relapse ra...
Status
Terminated
Location
Research Site
Start Date
2015-05
Trial ID
NCT02323269
Treatments Being Tested
The primary objective of the study is to investigate whether treatment with...
Status
Terminated
Location
Research Site
Start Date
2015-05
Trial ID
NCT02430532
Treatments Being Tested
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Research Site
Start Date
2010-06
Trial ID
NCT01156311
Treatments Being Tested
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00451451
Treatments Being Tested
In this study, researchers will learn more about the study drugs diroximel ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-16
Trial ID
NCT07483632
The goal of this clinical trial is to evaluate the efficacy and safety\] in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07138833
Treatments Being Tested
The purpose of this study is to measure two different formulations of BG000...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01069913
Treatments Being Tested
The primary objective of this study is to evaluate the effect of BG00012 (d...
Status
Completed
Location
Research Site
Start Date
2015-09-30
Trial ID
NCT02410200
Treatments Being Tested